Welcome to the Tamaris-Study website.
Slide the cursor over the arrows pointing to the various sections of the ring to obtain an overview of all the information and actions available to you after identification. You can quickly check whether any of your patients presenting chronic leg ulcers may be eligible for inclusion in the phase III Tamaris study protocol.

After identification, you will have access to the results of the Talisman study, indicating our new therapeutic objective for patients suffering from chronic leg ulcers: to extend life without amputation.

Patient Profile: Eligibility – Inclusion criteria

Study treatment: Therapeutic angiogenesis: nature, mode of action, access to a published article presenting the results of the Phase II Talisman study

Tamaris study: Design, inclusion and exclusion criteria, evaluation criteria – if any of your patients meets these criteria, please ask to be contacted.

CLI: Update on Critical Limb Ischaemia (CLI), including a scientific dossier, and on-line slide shows and videos: pathophysiopathology, diabetic ulcer, chronic tissue loss, management, etc.

Information for your patients: conditions of participation in the Tamaris study to communicate to your patients suffering from tissue loss related to arterial disease.

Tools: Access to complementary international data.

To be contacted: If you already have a DocCheck account, you will be put in touch with a medical advisor after identification. Otherwise, please complete the DocCheck registration form.